Bifogade filer
PDF
Kurs
+6,00%
Likviditet
10,5 MSEK
Kalender
| Est. tid* | ||
| 2026-02-06 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-24 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-18 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-07 | N/A | X-dag ordinarie utdelning HUM 1.00 SEK |
| 2025-05-06 | N/A | Årsstämma |
| 2025-04-24 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-02-06 | - | Bokslutskommuniké 2024 |
| 2024-10-23 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-19 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-08 | - | X-dag ordinarie utdelning HUM 0.00 SEK |
| 2024-05-07 | - | Årsstämma |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-08 | - | Bokslutskommuniké 2023 |
| 2023-10-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-21 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | - | X-dag ordinarie utdelning HUM 0.00 SEK |
| 2023-05-09 | - | Årsstämma |
| 2023-05-04 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-09 | - | Bokslutskommuniké 2022 |
| 2022-11-10 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-11 | - | X-dag ordinarie utdelning HUM 0.00 SEK |
| 2022-05-10 | - | Årsstämma |
| 2022-05-05 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-10 | - | Bokslutskommuniké 2021 |
| 2021-11-11 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-20 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | - | X-dag ordinarie utdelning HUM 0.00 SEK |
| 2021-05-11 | - | Årsstämma |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-11 | - | Bokslutskommuniké 2020 |
| 2020-11-06 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-08 | - | X-dag ordinarie utdelning HUM 0.00 SEK |
| 2020-05-07 | - | Årsstämma |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-13 | - | Bokslutskommuniké 2019 |
| 2019-05-10 | - | X-dag ordinarie utdelning HUM 0.70 SEK |
| 2019-05-09 | - | Årsstämma |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-11-16 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-17 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | - | X-dag ordinarie utdelning HUM 0.60 SEK |
| 2018-05-16 | - | Årsstämma |
| 2018-05-16 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-21 | - | Bokslutskommuniké 2017 |
| 2017-11-16 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-18 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-19 | - | X-dag ordinarie utdelning HUM 0.50 SEK |
| 2017-05-18 | - | Årsstämma |
| 2017-05-18 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-23 | - | Bokslutskommuniké 2016 |
| 2016-11-18 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-19 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-19 | - | Kvartalsrapport 2016-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
Under the authorisation from the annual general meeting 2024, the board of Humana AB has resolved to repurchase up to 1,000,000 own shares for the purpose of enabling the improvement of the company's capital structure and to increase the flexibility for the board in connection with potential future corporate acquisitions.
Any repurchase will be made on Nasdaq Stockholm in accordance with the Nordic Main Market Rulebook for Issuers of Shares and take place before the annual general meeting 2025. Own shares may be repurchased to the extent the company's holdings of own shares in total amounts to no more than ten per cent of the total number of shares in the company.
The shares will be repurchased in cash and at a price within the stock market price interval registered at any given time, such interval being the interval between the highest purchase price and the lowest sales price.
The repurchase of shares will be managed by an investment firm or financial institution and in accordance with the applicable rules and regulations in the Nordic Main Market Rulebook for Issuers of Shares.
For information on the implementation of the share repurchases, please see www.nasdaq.com. Repurchase of shares will not be press released separately, unless mandatory disclosure obligations apply.
The total number of shares in the company amounts to 51,826,058, whereof no own shares are held
by the company at the time of this press release.
For more information, please contact:
Christoffer Herou, CFO, +46 72 582 86 16, christoffer.herou@humana.se
Ewelina Pettersson, Head of IR, +46 73 074 79 12, ewelina.pettersson@humana.se